- Home
- ELVA vs PALI Comparison
ELVA vs PALI Comparison
Compare ELVA & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELVA | PALI |
|---|---|---|
| Founded | 1996 | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 329.2M | 359.7M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ELVA | PALI |
|---|---|---|
| Price | $6.90 | $2.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $14.00 | $11.29 |
| AVG Volume (30 Days) | 599.1K | ★ 1.4M |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.06 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $260,000.00 |
| Revenue This Year | $34.68 | N/A |
| Revenue Next Year | $51.48 | N/A |
| P/E Ratio | $78.51 | ★ N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $4.10 | $0.55 |
| 52 Week High | $12.78 | $2.86 |
Technical Indicators
Market Signals| Indicator | ELVA | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 40.68 | 48.11 |
| Support Level | $6.23 | $1.81 |
| Resistance Level | $8.98 | $2.18 |
| Average True Range (ATR) | 0.35 | 0.09 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 29.70 | 29.51 |
Price Performance
Historical ComparisonAbout ELVA Electrovaya Inc.
Electrovaya Inc is a technology-focused lithium-ion battery company engaged in designing, developing and manufacturing battery cells, modules and systems based on its proprietary Infinity Battery Technology, which provides high safety performance, long cycle life and durability. The Company supplies low-voltage and high-voltage battery systems for industrial and transportation markets, including material-handling equipment, robotic vehicles, electric buses and trucks, and energy-storage installations, and its products are suitable for mission-critical applications. it maintains an expanding intellectual-property portfolio, develops next-generation solid-state and hybrid solid-state battery technologies, and sells its products through OEM relationships, dealer networks and direct sales.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.